Literature DB >> 21791438

Lymphangiogenesis in deep infiltrating endometriosis.

S Keichel1, M-L Barcena de Arellano, U Reichelt, W F J Riedlinger, A Schneider, C Köhler, S Mechsner.   

Abstract

BACKGROUND: In patients diagnosed with deep infiltrating endometriosis (DIE), foci of endometriosis are detected in mesorectal lymph nodes (LNs) after segmental bowel resection and in pelvic sentinel LNs. Lymph vessels (LVs) seem to be the possible routes for the dissemination of endometriotic cells from DIE-lesions to LN. Therefore, we conducted a study to investigate the occurrence and density of LV and lymphangiogenic growth factors in DIE.
METHODS: Included in this study were 38 premenopausal women who underwent surgery due to symptomatic rectovaginal DIE. In order to identify LV, immunohistochemical analysis with anti-Podoplanin (D2-40), LYVE-1 and Prox-1 was performed. Furthermore, the expression of VEGF-C and VEGF-D in endometriotic tissue was investigated.
RESULTS: LV density (LVD) of DIE lesions was significantly higher compared with healthy corresponding tissue. All LV makers could be detected, and the density of LYVE-1- or Prox-1-positive LV was significantly higher than that of D2-40-positive LV. Endometriotic epithelial cells and stromal cells showed a moderate to strong VEGF-C and VEDF-D expression.
CONCLUSIONS: DIE lesions have lymphangiogenic properties, probably leading to endometriosis-like cells in lymphatic vessels and LNs featuring a loco-regional disease.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21791438     DOI: 10.1093/humrep/der230

Source DB:  PubMed          Journal:  Hum Reprod        ISSN: 0268-1161            Impact factor:   6.918


  10 in total

Review 1.  The endometrial lymphatic vasculature: function and dysfunction.

Authors:  Jane E Girling; Peter A W Rogers
Journal:  Rev Endocr Metab Disord       Date:  2012-12       Impact factor: 6.514

2.  Defining future directions for endometriosis research: workshop report from the 2011 World Congress of Endometriosis In Montpellier, France.

Authors:  Peter A W Rogers; Thomas M D'Hooghe; Asgerally Fazleabas; Linda C Giudice; Grant W Montgomery; Felice Petraglia; Robert N Taylor
Journal:  Reprod Sci       Date:  2013-02-20       Impact factor: 3.060

Review 3.  Intrahepatic endometriosis as differential diagnosis: case report and literature review.

Authors:  Georg Fluegen; Frank Jankowiak; Luisa Zacarias Foehrding; Feride Kroepil; Wolfram T Knoefel; Stefan A Topp
Journal:  World J Gastroenterol       Date:  2013-08-07       Impact factor: 5.742

4.  Estrogen receptor β regulates endometriotic cell survival through serum and glucocorticoid-regulated kinase activation.

Authors:  Diana Monsivais; Matthew T Dyson; Ping Yin; Antonia Navarro; John S Coon; Mary Ellen Pavone; Serdar E Bulun
Journal:  Fertil Steril       Date:  2016-01-28       Impact factor: 7.329

Review 5.  Giant endometrial cyst of the liver: a case report and review of the literature.

Authors:  M A De Riggi; F Fusco; G Marino; A Izzo
Journal:  G Chir       Date:  2016 Mar-Apr

6.  Impact of medical and surgical treatment of endometriosis on the cure of endometriosis and pain.

Authors:  Liselotte Mettler; R Ruprai; Ibrahim Alkatout
Journal:  Biomed Res Int       Date:  2014-12-15       Impact factor: 3.411

7.  (18)F-fluorodeoxyglucose positron emission tomography/computed tomography-positive lymph node endometriosis masquerading as lymph node metastasis of a malignant tumor.

Authors:  Makoto Akiyama; Izumi Suganuma; Taisuke Mori; Izumi Kusuki; Haruo Kuroboshi; Fumitake Ito; Hiroshi Matsushima; Morio Sawada; Jo Kitawaki
Journal:  Case Rep Obstet Gynecol       Date:  2014-08-10

8.  Does the Use of the "Proseek® Multiplex Oncology I Panel" on Peritoneal Fluid Allow a Better Insight in the Pathophysiology of Endometriosis, and in Particular Deep-Infiltrating Endometriosis?

Authors:  Alexandra Perricos; René Wenzl; Heinrich Husslein; Thomas Eiwegger; Manuela Gstoettner; Andreas Weinhaeusel; Gabriel Beikircher; Lorenz Kuessel
Journal:  J Clin Med       Date:  2020-06-26       Impact factor: 4.241

Review 9.  Endometriosis-associated ovarian carcinomas: insights into pathogenesis, diagnostics, and therapeutic targets-a narrative review.

Authors:  Eleftherios P Samartzis; S Intidhar Labidi-Galy; Michele Moschetta; Mario Uccello; Dimitrios R Kalaitzopoulos; J Alejandro Perez-Fidalgo; Stergios Boussios
Journal:  Ann Transl Med       Date:  2020-12

10.  IL-33 activates group 2 innate lymphoid cell expansion and modulates endometriosis.

Authors:  Jessica E Miller; Harshavardhan Lingegowda; Lindsey K Symons; Olga Bougie; Steven L Young; Bruce A Lessey; Madhuri Koti; Chandrakant Tayade
Journal:  JCI Insight       Date:  2021-12-08
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.